MAAT INDEX

CLAIM #40554 · Medtronic PLC (MDT) · 2025Q2 earnings call · Nov 19, 2024 · due Apr 25, 2025

And we translated that 5% organic top line growth into 8% EPS growth on a constant currency basis and we remain on track to deliver high single-digit EPS growth on a reported basis in the back half of the fiscal year.

Geoff Martha · CEO

PENDING
graded after results covering Apr 25, 2025 are reported

In context

ver-year basis and compare our second fiscal quarter against our competitors’ third calendar quarter. Reconciliations of all non-GAAP financial measures can be found in our earnings press release or on our website at investorrelations.medtronic.com. And finally, our EPS guidance does not include any charges or gains that would be reported as non-GAAP adjustments to earnings during the fiscal year. With that, let’s head into the studio and hear about the quarter. Geoff Martha: Hello, everyone, and thanks for tuning in today. Our momentum is building as we keep executing on our commitments, delivering yet another quarter of strong results that came in ahead of expectations and another guidance raise. This makes it eight quarters in a row now of solid mid-single-digit organic revenue growth. And we translated that 5% organic top line growth into 8% EPS growth on a constant currency basis and we remain on track to deliver high single-digit EPS growth on a reported basis in the back half of the fiscal year. We know that innovation matters. And innovation is what really is driving our growth today across multiple areas. We're seeing strong performance from franchises like TAVR, PFA, leadless pacemakers, diabetes, spine and neuromodulation, just to name a few. And we're confident that this diversified growth will keep going, especially with the strength of our pipeline in high-impact markets like hypertension, which is a big, exciting opportunity for us. If you look at our recent performance, it's clear. The foundation of the company is much stronger. We've integrated a real performance mindset alongside our mission-driven culture and it's making a difference. And as we continue to drive durable top line growth, use our scale to deliver leveraged earnings, generate strong free cash flow, pursu

Verify independently

SEC filings for MDT · Claim quote is verbatim from the 2025Q2 earnings call.